262 related articles for article (PubMed ID: 6403466)
1. Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.
Zollinger WD; Mandrell RE
Infect Immun; 1983 Apr; 40(1):257-64. PubMed ID: 6403466
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.
Zollinger WD; Moran EE; Devi SJ; Frasch CE
Infect Immun; 1997 Mar; 65(3):1053-60. PubMed ID: 9038315
[TBL] [Abstract][Full Text] [Related]
3. Complement-mediated bactericidal activity of human antibodies to poly alpha 2-->8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B.
Mandrell RE; Azmi FH; Granoff DM
J Infect Dis; 1995 Nov; 172(5):1279-89. PubMed ID: 7594665
[TBL] [Abstract][Full Text] [Related]
4. Measurement of growth-inhibiting (bactericidal) antibodies in patients with meningococcal meningitis and in subjects immunized with meningococcal polysaccharide vaccine by a [3H]thymidine assay.
Hassan-King M; Greenwood BM; Whittle HC
J Clin Microbiol; 1985 Jul; 22(1):136-8. PubMed ID: 3926814
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C.
Westerink MA; Campagnari AA; Wirth MA; Apicella MA
Infect Immun; 1988 May; 56(5):1120-7. PubMed ID: 3128477
[TBL] [Abstract][Full Text] [Related]
6. Immunological properties of monoclonal antibodies specific for meningococcal polysaccharides: the protective capacity of IgM antibodies specific for polysaccharide group B.
Moreno C; Hewitt J; Hastings K; Brown D
J Gen Microbiol; 1983 Aug; 129(8):2451-6. PubMed ID: 6415230
[TBL] [Abstract][Full Text] [Related]
7. Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis.
Kasper DL; Winkelhake JL; Brandt BL; Artenstein MS
J Infect Dis; 1973 Apr; 127(4):378-87. PubMed ID: 4121052
[No Abstract] [Full Text] [Related]
8. Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response.
Herva E; Leinonen M; Käyhty H; Mäkelä PH; Vetoniemi-Korhonen SL
J Infect; 1983 Jan; 6(1):55-60. PubMed ID: 6411822
[TBL] [Abstract][Full Text] [Related]
9. The immune response to the capsular polysaccharide of Neisseria meningitidis group B.
Romero JD; Outschoorn IM
Zentralbl Bakteriol; 1997 Feb; 285(3):331-40. PubMed ID: 9084108
[No Abstract] [Full Text] [Related]
10. Class-specific antibody response to group B Neisseria meningitidis capsular polysaccharide: use of polylysine precoating in an enzyme-linked immunosorbent assay.
Leinonen M; Frasch CE
Infect Immun; 1982 Dec; 38(3):1203-7. PubMed ID: 6818147
[TBL] [Abstract][Full Text] [Related]
11. A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses.
Granoff DM; Maslanka SE; Carlone GM; Plikaytis BD; Santos GF; Mokatrin A; Raff HV
Clin Diagn Lab Immunol; 1998 Jul; 5(4):479-85. PubMed ID: 9665952
[TBL] [Abstract][Full Text] [Related]
12. Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1.
Jennings HJ; Gamian A; Michon F; Ashton FE
J Immunol; 1989 May; 142(10):3585-91. PubMed ID: 2469720
[TBL] [Abstract][Full Text] [Related]
13. Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy.
D'Amelio R; Agostoni A; Biselli R; Brai M; Caruso G; Cicardi M; Corvetta A; Fontana L; Misiano G; Perricone R
Scand J Immunol; 1992 May; 35(5):589-95. PubMed ID: 1579859
[TBL] [Abstract][Full Text] [Related]
14. Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.
Selander B; Käyhty H; Wedege E; Holmström E; Truedsson L; Söderström C; Sjöholm AG
J Clin Immunol; 2000 Mar; 20(2):138-49. PubMed ID: 10821465
[TBL] [Abstract][Full Text] [Related]
15. N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.
Pon RA; Lussier M; Yang QL; Jennings HJ
J Exp Med; 1997 Jun; 185(11):1929-38. PubMed ID: 9166422
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.
Hurpin CM; Carosella ED; Cazenave PA
Hybridoma; 1992 Dec; 11(6):677-87. PubMed ID: 1284118
[TBL] [Abstract][Full Text] [Related]
17. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
Skevakis L; Frasch CE; Zahradnik JM; Dolin R
J Infect Dis; 1984 Mar; 149(3):387-96. PubMed ID: 6425422
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid.
Granoff DM; Bartoloni A; Ricci S; Gallo E; Rosa D; Ravenscroft N; Guarnieri V; Seid RC; Shan A; Usinger WR; Tan S; McHugh YE; Moe GR
J Immunol; 1998 May; 160(10):5028-36. PubMed ID: 9590252
[TBL] [Abstract][Full Text] [Related]
19. Serum bactericidal antibody assays - The role of complement in infection and immunity.
McIntosh ED; Bröker M; Wassil J; Welsch JA; Borrow R
Vaccine; 2015 Aug; 33(36):4414-21. PubMed ID: 26187262
[TBL] [Abstract][Full Text] [Related]
20. Control of meningococcal meningitis with meningococcal vaccines.
Artenstein MS
Yale J Biol Med; 1975 Jul; 48(3):197-200. PubMed ID: 808913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
